Servaas Michielssens is the Head of Healthcare at Candriam since 2024. Previously, he was Senior Fund Manager and Biotechnology Analyst with Candriam from 2016 to 2022.
His other financial experience includes two years in private equity (from 2022), and two years as a risk analyst at Axa. Servaas began his career as a Doctoral Researcher at Katholieke Universiteit Leuven in 2007 and joined Max Planck Institute in Germany as a researcher in 2012.
Servaas holds a Master in Science and a Ph.D. in Chemistry (Katholieke Universiteit Leuven). He has been a CFA Charterholder since 2018.